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Edited by Veli-Pekka LehtoAbstract Cholesterol is a major component of skin lipids and
acts as a regulator of vesicular traﬃcking and signal transduc-
tion. However, the function of cholesterol on matrix metallopro-
teinases (MMPs) expression of human skin is not fully
understood. Here, we investigated the eﬀects of cholesterol on
MMP-9 expression in normal human keratinocytes (NHK)
and HaCaT cells. Basal level of MMP-9 expression was de-
creased by cholesterol in NHK. On the other hand, MMP-9
expression was increased by the cholesterol depletion agent,
methyl-b-cyclodextrin (MbCD), while it was inhibited by choles-
terol repletion in HaCaT cells. MbCD induced ERK and JNK
phosphorylation were prevented by cholesterol repletion. The
inhibition of ERK and JNK decreased MbCD-induced MMP-
9 expression. Therefore, our results suggest that cholesterol reg-
ulates MMP-9 expression through ERK and JNK-dependent
pathways.
 2007 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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AP-11. Introduction
The matrix metalloproteinases (MMPs), of which there are
more than 24 human MMPs, are a family of zinc-binding
endopeptidases capable of degrading extracellular matrix
(ECM) components including collagen and proteoglycans [1].
MMPs are also involved in modulation of growth factor and
cytokine function [2–4]. In human skin, various MMPs are ex-
pressed in several dermatoses or in cutaneous wound healing
[5–7].
Two gelatinases, 72 kDa type IV collagenase (MMP-2) and
97 kDa type IV collagenase (MMP-9), contribute to a variety
of pathological conditions including cancer, infectious dis-
eases, wound healing, inﬂammation, and vascular diseases
[5–8]. MMP-9 is known to be produced by a variety of cells
such as keratinocytes, leukocytes, macrophages, and epithelial
tumoral cells [4,6]. MMP-9 also contributes to keratinocyteAbbreviations:MMP-9, matrix metalloproteinase-9; MbCD, methyl-b-
cyclodextrin; AP-1, activator protein-1
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doi:10.1016/j.febslet.2007.06.074hyperproliferation and progression to invasive cancer in a
mouse model of oncogene-derived skin carcinogenesis [8]. In
addition, the expression of MMP-9 is over-expressed in middle
ear cholesteatoma [9].
Cholesterol has primarily been considered an essential com-
ponent of all cell membranes and is an important structural
component and modulator of cell ﬂuidity [10–12]. It is also
essential for biological functions ranging from membrane traf-
ﬁcking to signal transduction [13]. Cholesterol is a major end-
product of the isoprenoid biosynthetic pathway or, alterna-
tively, the mevalonate pathway [14].
Extracellular cholesterol located in the horny layer of the hu-
man skin epidermis is an essential component for skin barrier
function. Cholesterol is synthesized in epidermal keratinocytes
[15], and promotes corniﬁded envelope formation in the late
stages of epidermal diﬀerentiation [16]. On the other hand,
intracellular cholesterol may also activate various signaling
pathways [13,17]. Cholesterol inhibits EGF-induced EGFR
tyrosine phosphorylation, suggesting that the presence of cho-
lesterol negatively regulates EGFR kinase activity and also,
cholesterol depletion up-regulates involucrin expression in
keratinocytes [18,19].
The aim of this study was to determine the eﬀects of choles-
terol on MMP-9 expression and to investigate the molecular
mechanisms for MMP-9 regulation by cholesterol. We demon-
strated that the cholesterol may regulate ERK- and JNK-
dependent pathways, which may play important roles in the
modulation of MMP-9 expression in epidermal keratinocytes.2. Materials and methods
2.1. Cell cultures
Human keratinocytes were cultured as previously described [19].
Keratinocytes were cultured in keratinocyte growth media (KGM)
(Clonetics, San Diego, CA), which was composed of MCDB 153 med-
ium supplemented with epidermal growth factor (10 ng/ml), bovine
pituitary extract (70 lg/ml), hydrocortisone (0.5 lg/ml), penicillin
(100 lg/ml), streptomycin (100 lg/ml), and fungizone (0.25 lg/ml).
Third-passage keratinocytes were used. HaCaT (immortalized kerati-
nocytes) and HT1080 cells were cultured in Dulbecco’s modiﬁed Ea-
gle’s medium (DMEM) supplemented with 10% fetal bovine serum
(FBS), 2 mM glutamine, 100 IU/ml penicillin and 100 lg/ml strepto-
mycin.
2.2. Cholesterol and MbCD treatment
For experiments, normal human keratinocytes (NHK) and HaCaT
cells were maintained in keratinocyte basal media (KBM) without sup-
plements (EGF, bovine pituitary extract, and hydrocortisone) and
DMEM without FBS for 24 h, respectively; cells were then incubatedblished by Elsevier B.V. All rights reserved.
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Louis, MO) and/or 100 lg/ml cholesterol (stock solution; 3 mg/ml in
DMEM, Sigma) was added for 1 h. Culture media were replaced with
fresh media without FBS and the cells were further incubated for the
indicated times. HT1080 cells were used as a positive control for
MMP-9. In experiments involving MAPK inhibitors, U0126 and
SP600125 (stock solution; 10 mM in DMSO, Calbiochem, San Diego,
CA), were added 30 min prior to 10 mMMbCD and/or 100 lg/ml cho-
lesterol.2.3. Cholesterol assays
Cellular cholesterol assay was performed using a commercial kit
(Shin Yang, Seoul, Korea) according to the manufacturer’s instruc-
tions. Brieﬂy, cells were washed twice with 1 ml of cold PBS, and lipids
were extracted with 2 ml of extraction buﬀer [hexane/isopropyl alcohol
(3:2, v/v)] for 1 h at room temperature. The organic extract was trans-
ferred to glass tubes and the solvent was removed in a SpeedVac. The
lipid was solubilized in 1 ml of the cholesterol assay kit buﬀer solution
and vortexed to solubilize the lipid pellet. Samples were incubated for
1 h at 37 C prior to measuring absorbance at 505 nm.
2.4. MTT assays
The viability of cells was monitored after various concentrations of
cholesterol and/or MbCD treatment. 3-(4,5-Dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) was used for the quantiﬁcation of
living metabolically active cells. Mitochondrial dehydrogenases metab-
olize MTT to a purple formazan dye, which was measured photomet-
rically at 570 nm [20].
2.5. Western blotting
Western blotting was performed as previously described [21]. Cells
were lysed with lysis buﬀer (50 mM Tris–HCl, pH 7.4, 150 mM NaCl,
1 mM EDTA, 1 mM EGTA, 10 lg/ml aprotinin, 10 lg/ml leupeptin,
5 mM phenylmethylsulfonyl ﬂuoride (PMSF), and 1 mM DTT) con-
taining 1% Triton X-100. Insoluble debris was removed by centrifuga-
tion at 12000 rpm for 15 min, and protein content was determined
using Bradford reagent (Bio-Rad, Hercules, CA). Equal amounts of
protein were resolved on gradient 10% SDS–PAGE gels and electro-
phoretically transferred to PVDF membranes (Amersham, Bucking-
hamshire, UK). Membranes were subsequently blocked with 5%
skim milk in TBS/T (20 mM Tris–HCl, pH 7.6, 137 mM NaCl, and
0.05% Tween 20) and incubated with the anti-humanMMP-9 antibody
(Neomarker, Fremont, CA), or with antibodies against ERK, JNK,
p38, c-Jun, and c-Fos (Cell Signaling Technology, Beverly, MA),
and anti-actin antibody (Santa Cruz Biotechnology, Santa Cruz,
CA). Immunoreactive proteins were visualized by enhanced chemilu-
minescence (Amersham), and exposed to Kodak X-ray ﬁlm. Band
density is measured using TINA2.0 software (TINA; Raytest Isotope-
nme[b]gerate, Germany).2.6. Zymography
To determine the activity of secreted MMP-9 in culture media,
Zymography was performed in 10% polyacrylamide gels that had been
cast in the presence of gelatin as previously described [21]. Brieﬂy, sam-
ples were suspended in loading buﬀer (10% SDS, 25% glycerol, 0.25 M
Tris (pH 6.8), and 0.1% bromophenol blue) and without prior denatur-
ation run on 10% SDS–PAGE gels containing 0.5 mg/ml gelatin. After
electrophoresis, gels were washed to remove SDS and incubated for
30 min at room temperature in renaturing buﬀer (50 mM Tris, 5 mM
CaCl2, 0.02% NaN3, 1% Triton X-100). In the next steps, gels were
incubated for 24 h at 37 C in a developing buﬀer [50 mM Tris (pH
7.8), 5 mM CaCl2, 0.1 of 5 M NaCl, and 1% Triton X-100]. Gels were
subsequently stained with 0.5% Coomassie Brilliant Blue G-250 and
destained in 30% methanol, 10% acetic acid to detect gelatinolytic
activity. Signal intensities were quantiﬁed using a densitometric pro-
gram (TINA, Raytest Isotopenme[b]gerate, Germany).2.7. RT-PCR
Total RNA was extracted from HaCaT cells using TRIzol (Invitro-
gen, Carlsbad, CA) according to manufacturer’s protocol. Extracted
RNA was electrophoresed in 1% agarose gels to conﬁrm its quality
and quantity. Equal amounts of RNA (1 lg) were reverse transcribed
using a ﬁrst-strand cDNA synthesis kit (MBI Fermentas, Vilnius, Lith-uania). Semiquantitative PCR was performed using speciﬁc primers:
human MMP-9 (forward, 5 0-CCC GGA CCA AGG ATA CAG-30; re-
verse, 5 0-GGC TTT CTC TCG GTA CTG-3 0) and as an internal con-
trol, GAPDH (forward, 5 0-ATT GTT G CC ATC AAT GAC CC-3 0;
reverse, 5 0-AGT AGA GGC AGG GAT GAT GT-3 0). The PCR con-
ditions used were: one cycle of initial denaturation (for 5 min at 94 C),
21 cycles (GAPDH) or 30 cycles (MMP-9) of ampliﬁcation (for 1 min
at 94 C, for 1 min at 60 C, and for 1 min at 72 C) and one cycle of
ﬁnal extension (for 10 min at 72 C). Reaction products were electro-
phoresed in 2% agarose gels and visualized with ethidium bromide
(EtBr).
2.8. Electrophoretic mobility shift assays (EMSA)
EMSA were performed using a commercial kit, according to the
manufacturer’s instructions (Promega, Madison, WI). Brieﬂy, AP-1
(5 0-CGC TTG ATG CAG CCG GAA-30) consensus oligonucleotides
were end-labeled by T4 polynucleotide kinase using [c-32P] ATP
(3000 Ci/mmol; Amersham-Pharmacia Biotech. Piscataway, NJ).
Binding reactions were performed for 30 min on ice with 5 lg of pro-
tein in 20 ll of binding buﬀer containing 4% glycerol, 20 mM HEPES
(pH 7.9), 1 mM MgCl2, 0.5 mM EDTA, 0.5 mM DTT, 50 mM NaCl,
10 mM Tris–HCl (pH 7.5), and 50 lg/mL of poly (dI–dC) and 20000–
25000 dpm of 32P-labeled oligonucleotide. DNA–protein complexes
were separated from unbound oligonucleotide by electrophoresis
through 6% DNA retardation gels (Invitrogen) using 0.5· Tris–borate.
2.9. Statistical analysis
Statistical signiﬁcance was determined using the Student’s t-test. Re-
sults are presented as means ± S.E.M. All P-values were two-tailed and
signiﬁcance was accepted when P was <0.05.3. Results
3.1. Cholesterol decreased basal MMP-9 expression in normal
human keratinocytes
To investigate the eﬀects of cholesterol on MMP-9 expres-
sion, NHK were treated with the indicated concentration of
cholesterol for 1 h. The culture media were harvested at 72 h
after cholesterol treatment to measure MMP-9 expression by
Western blot analysis and Zymography, respectively. Because
basal MMP-9 expression is higher in NHK than in HaCaT
cells, we utilized NHK. MMP-9 expression was dose-depen-
dently decreased by cholesterol treatment. The level of
MMP-9 protein decreased signiﬁcantly by 68 ± 3.2% and
82 ± 4.9% of the control level at the concentrations of
100 lg/ml and 200 lg/ml of cholesterol, respectively
(Fig. 1A). MMP-9 expression measured by Zymography also
decreased signiﬁcantly by 53 ± 6.2%, 70 ± 6.5% and
70 ± 7.9% of the control level at the concentrations of 50 lg/
ml, 100 lg/ml and 200 lg/ml of cholesterol, respectively
(Fig. 1B). Cell viability was not changed by cholesterol treat-
ment (Fig. 1C).
3.2. MbCD-induced MMP-9 expression is inhibited by
cholesterol repletion in HaCaT cells
We next investigated the eﬀects of cholesterol repletion on
MbCD-induced MMP-9 expression in HaCaT cells. Cells were
treated with 10 mM MbCD with or without cholesterol (0–
200 lg/ml, respectively) for 1 h and then the culture media
were then harvested to measure the levels of MMP-9 mRNA
and protein expression at 24 h and 72 h post-treatment, respec-
tively.
We examined the eﬀects of cholesterol repletion on MbCD-
induced MMP-9 mRNA expression in HaCaT cells. Choles-
terol depletion by MbCD signiﬁcantly increased the level of
Fig. 1. Cholesterol reduces MMP-9 expression in normal human keratinocytes (NHK). After serum-starvation for 24 h, NHK were treated with the
indicated concentrations of cholesterol for 1 h and then further cultured for 72 h. In culture media, MMP-9 expression was determined by (A)
Western blotting and (B) Zymography. (C) Cell viability was analyzed by MTT assays. These results are representative of three independent
experiments. HT, HT-1080 cells as a positive control for MMP-9. Values shown are means ± S.E.M. *P < 0.05, **P < 0.01 vs. control. Con; control.
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expression was reduced to the control level by repletion of
100 lg/ml of cholesterol in HaCaT cells (Fig. 2A). We also
demonstrated that cholesterol depletion by MbCD increased
MMP-9 protein levels by 300 ± 35.2% in HaCaT cells, and
repletion of 100 lg/ml and 200 lg/ml of cholesterol reversed
the MbCD-induced MMP-9 expression signiﬁcantly to the
120 ± 10.2% and 100 ± 11.3% of control level, respectively
(Fig. 2B). MMP-9 levels measured by Zymography also in-
creased signiﬁcantly by 700 ± 161.2% with MbCD treatment
in HaCaT cells. Repletion of 50 lg/ml, 100 lg/ml and 200 lg/
ml of cholesterol signiﬁcantly decreased the MbCD-induced
MMP-9 expression to 200 ± 94.1%, 100 ± 13.2% and 53 ±
12.1% of control level, respectively (Fig. 2C). In this study, cell
viability was not changed by MbCD and/or cholesterol treat-
ment (Fig. 2D). The amount of intracellular cholesterol was
signiﬁcantly decreased after MbCD treatment for 1 h, while
it was reversed by cholesterol repletion (Fig. 2E). These results
suggest that MMP-9 mRNA and protein expression may be
regulated by cholesterol.
3.3. Cholesterol depletion increased ERK and JNK
phosphorylation and AP-1 DNA binding activity, while
these eﬀects were prevented by cholesterol repletion
To investigate the molecular mechanisms involved in the
cholesterol depletion-induced MMP-9 expression and activity,
HaCaT cells were treated with 10 mM MbCD with or without
100 lg/ml cholesterol for the indicated times (15–60 min).
ERK and JNK phosphorylation were greatly increased by cho-
lesterol depletion at 60 min after MbCD treatment (Fig. 3A).
However, cholesterol depletion by MbCD did not induce p38
phosphorylation. On the other hand, these MbCD-induced
phosphorylation of ERK and JNK were signiﬁcantly inhibited
by cholesterol repletion (Fig. 3A).Next, we investigated the expression and phosphorylation of
c-Jun and c-Fos proteins, which are JNK and ERK substrates,
respectively, and are the main components of AP-1 transcrip-
tion factor. After serum starvation for 24 h, HaCaT cells were
treated with 10 mM MbCD with or without 100 lg/ml choles-
terol simultaneously for the indicated times. We found that the
level of total c-Jun was increased from 1 h up to 4 h post-
MbCD treatment, and the MbCD-induced expression of total
c-Jun was inhibited by cholesterol repletion (Fig. 3B). The
phosphorylation of c-Jun was also peaked at 1 h post-MbCD
treatment, and this increase was inhibited by cholesterol reple-
tion (Fig. 3B). The level of total c-Fos protein also increased
maximally at 1 h post-MbCD treatment, and this induction
was also prevented by cholesterol repletion (Fig. 3B).
Using EMSA, we observed that cholesterol depletion by
MbCD increased the AP-1 DNA binding activity. AP-1
DNA binding activity increased greatly at 2 h after MbCD
treatment (Fig. 3C). This MbCD-induced activity of AP-1
was decreased by cholesterol repletion (Fig. 3C). Our results
indicate that cholesterol depletion may increase the expression
and phosphorylation of c-Jun and c-Fos proteins, leading to
activation of AP-1 transcription factor.
3.4. Inhibition of ERK and JNK prevented MbCD-induced
MMP-9 expression in HaCaT cells
Finally, we examined the eﬀects of MEK (U0126) and JNK
(SP600125) inhibitors on MbCD-induced MMP-9 expression
in HaCaT cells. Cells were pretreated with each inhibitor for
30 min and then further incubated with 10 mM MbCD for
1 h. U0126 and SP600125 completely inhibited MbCD-in-
duced MMP-9 expression (Fig. 4A and B) in HaCaT cells.
Thus, we demonstrate that cholesterol may regulate MMP-9
expression through ERK/JNK pathway in human keratino-
cytes.
Fig. 2. MbCD-induced MMP-9 expression is inhibited by cholesterol repletion in HaCaT cells. After serum-starvation for 24 h, HaCaT cells were
treated with 10 mM MbCD and/or cholesterol as indicated concentrations for 1 h and then further cultured for 24 h (mRNA) and 72 h (protein),
respectively. (A) MMP-9 mRNA level was determined by RT-PCR. In culture media, MMP-9 protein expression was determined by (B) Western
blotting and (C) Zymography. (D) Cell viability was analyzed by MTT assays. (E) Cholesterol assays described in Section 2. These results are
representative of three independent experiments. Values shown are means ± S.E.M. *P < 0.05, **P < 0.01 vs. control and P < 0.05, P < 0.01 vs.
3872 S. Kim et al. / FEBS Letters 581 (2007) 3869–38744. Discussion
MMP-9, also known as 92 kDa type IV collagenase or gela-
tinase B [22–24], has been reported to play important roles in
tumor invasion and metastasis, wound healing, and angiogen-
esis [8]. However, little is known about the regulatory eﬀects on
MMP-9 by cholesterol which is a major component of skin lip-
ids.
In this study, we investigated the eﬀect of cholesterol on
MMP-9 expression. Cholesterol treatment in cultured NHK
decreased basal MMP-9 expression. Also, induction of
MMP-9 expression by cholesterol depletion is reversed by cho-
lesterol repletion in HaCaT cells. Therefore, our results suggest
that cholesterol plays an inhibitory role in MMP-9 expression.
Here, we demonstrated that cholesterol depletion by MbCD
activated ERK and JNK, increased the total and phosphory-
lated c-Jun and c-Fos proteins, stimulated AP-1 DNA binding
activity, and that these eﬀects of cholesterol depletion were
inhibited by cholesterol repletion. Therefore, our results indi-
cate that reduction of intracellular cholesterol levels may playimportant roles in the activation of ERK- and JNK-dependent
pathways, which in turn may lead to activation of the AP-1
transcription factor. Consistent with our results, it was re-
ported that ERK activity is activated by acute depletion of
membrane cholesterol [25,26] and also, oxysterol-binding pro-
tein (OSBP) was found to function as a cholesterol-binding
scaﬀolding protein coordinating the activity of two phospha-
tases (PP2A and HePTP) to control the ERK signaling path-
way [26].
Recently, Li et al. reported that treatment of MbCD to hu-
man epidermoid carcinoma cell line (A431 cells) for more than
4 h decreased the level of phospho-Akt and phospho-ERK,
which are known to play critical roles in cell survival signaling
pathways, and induced apoptotic cell death [27]. We also ob-
served that treatment of MbCD to HaCaT cells for more than
2 h induced cell death (data not shown). In our study, the
MbCD treatment for 1 h did not aﬀect the cell viability at
all, and it decreased the level of intracellular cholesterol signif-
icantly. Consistent with our results, Li et al., also showed the
increased level of phospho-ERK after 1 h post-MbCD treat-
Fig. 3. MbCD-induced ERK, JNK phosphorylation, and AP-1 DNA binding activity are inhibited by cholesterol repletion in HaCaT cells. (A) After
serum-starvation for 24 h, HaCaT cells were treated with 10 mM MbCD and/or 100 lg/ml cholesterol, and then further cultured at 37 C for the
indicated times. ERK and JNK were measured in whole cell lysates by Western blotting with total- and phospho-ERK and JNK antibodies,
respectively. (B) Serum-starved cells were treated with 10 mM MbCD and/or 100 lg/ml cholesterol for 1 h and further cultured at 37 C for the
indicated times. Total and phospho-c-Jun, and total c-Fos were measured in whole cell lysates by Western blotting. (C) AP-1 DNA binding activity
was detected by EMSA in nuclear extracts (5 lg protein) as described in Section 2. The results are representative of three independent experiments.
Con; control.
Fig. 4. MbCD-induced MMP-9 expression is inhibited by MAPK
inhibitors, U0125 and SP600125 in HaCaT cells. After serum-
starvation for 24 h, HaCaT cells were pretreated for 30 min with
various inhibitors, including 10 lM U0126 (U) and 10 lM SP600125
(SP) prior to 10 mM MbCD treatment. The cells were then incubated
with or without 10 mM MbCD for 1 h, and further cultured at 37 C
for 72 h. The MMP-9 protein levels in cultured media were detected
by (A) Western blotting and (B) Zymography. These results are
representative of three independent experiments. Values shown are
means ± S.E.M. **P < 0.01 vs. control, P < 0.05, P < 0.01 vs.
MbCD-treated cells. Con; control.
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ERK signaling pathway after short-term treatment may play
some roles in maintaining cell viability.
The transcriptional regulation of MMP-9 has been well
investigated. The MMP-9 promoter has several transcription
factor-binding motifs, including AP-1, NF-jB, and SP1 [28].
AP-1 is a positive regulator of MMP-9 transcription [29] and
the three MAPKs, including ERK, JNK and p38, are known
to be involved in the regulation of MMP-9 transcription [30].
UV has also been reported to activate ERK and JNK/p38 ki-
nase, and these activated MAP kinases increase the expression
and activation of c-Fos and c-Jun, which are the main compo-nents of AP-1 transcription factor [30,31]. Activated AP-1
binds to its response element on the MMP-9 promoter to in-
crease the transcription of MMP-9 [30]. Consistent with the
UV-induced signaling pathways that lead to MMP-9 expres-
sion, we demonstrated that cholesterol depletion by MbCD
activated ERK- and JNK-dependent pathways resulting in in-
creased MMP-9 expression.
In summary, intracellular cholesterol levels regulates MMP-
9 expression in human epidermal keratinocytes. Our results
suggest that low cholesterol may activate ERK- and JNK-
dependent pathways, leading to activation of AP-1 transcrip-
tion factor that increases MMP-9 expression, while high
cholesterol may inhibit this activation. It has been well known
that MMP-9 was up-regulated by UV irradiation in human
skin and also increased in aged and photoaged human skin. In-
creased expression of MMP-9 is involved with collagen degra-
dation in UV-irradiated and aged/photoaged human skin
[29,32,33], leading to wrinkle formation and aged appearance.
Therefore, increasing cholesterol levels may provide a good
strategy to prevent MMP-9-mediated degradation of extracel-
lular matrix (ECM) in human skin.Acknowledgements: This research was supported by a grant (R11-2002-
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